Carfenazine
|  | |
| Systematic (IUPAC) name | |
|---|---|
| 1-(10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-10H-phenothiazin-2-yl)propan-1-one | |
| Clinical data | |
| License data | 
 | 
| Routes of administration | Oral | 
| Legal status | 
 | 
| Identifiers | |
| CAS Number | 2622-30-2 | 
| ATC code | none | 
| PubChem | CID 18104 | 
| IUPHAR/BPS | 7140 | 
| DrugBank | DB01038 | 
| ChemSpider | 17100 | 
| UNII | CLY16Y8Z7E | 
| ChEMBL | CHEMBL1201328 | 
| Synonyms | Proketazine, Carphenazin | 
| Chemical data | |
| Formula | C24H31N3O2S | 
| Molar mass | 425.6 g/mol | 
| 
 | |
| 
 | |
Carfenazine (INN), used in the form of carphenazine maleate (USAN), is an antipsychotic agent,[1] mainly used for the treatment of chronic schizophrenia.[2]
References
- ↑ Tislow, Richard (1961). "Pharmacology and toxicity of carphenazine". Diseases of Nervous System 22 (Suppl. No. 2): 7–13.
- ↑ Carphenazine, DrugBank
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.